- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04231916
High Resolution Thermal Imaging to Identify Vertebral Fractures in Children and Young People With Osteogenesis Imperfecta (THERMOI)
January 15, 2020 updated by: Sheffield Children's NHS Foundation Trust
Brittle bone disease also known as osteogenesis imperfecta (OI) is characterised by a defect in the bone tissue that leads to recurrent fractures and significant bone deformities in children.
These fractures include vertebral (spinal) fractures.
As a result, child with OI require regular clinic surveillance that includes repeated xrays of the spine.
in our pilot study the investigators plan to use a thermal imaging camera that can pick up changes in temperature to 0.03 degrees to determine whether the investigators can accurately identify vertebral fractures without the need for radiation.
in the first part of the study the investigators will compare the thermal images from the camera with the xrays to see if the investigators can pick up the vertebral fractures seen on the xray picture.
If this is possible, then the investigators will move on to phase 2 of the study which will investigate the ability of the thermal camera to pick up vertebral fractures without prior knowledge of where the fractures are located.
If this approach is successful this will help us to develop a nonradiation, lowcost painless way of identifying vertebral fractures in children with OI.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
- Patients with Osteogenesis Imperfecta (with known vertebral fractures)for phase one of the study.
- Patients with Osteogenesis Imperfecta for phase 2 of the study
- In both groups patients will be aged 5 years and over
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients aged 5-18 years
Patients with Osteogenesis Imperfecta (with known vertebral fractures)for phase one of the study. Patients with Osteogenesis Imperfecta for phase 2 of the study In both groups patients will be aged 5 years and over |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thermal imaging device
Time Frame: 15 minutes
|
The ability to pick up vertebral morphology and fractures in relation to spine X-rays
|
15 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2015
Primary Completion (Actual)
July 7, 2016
Study Completion (Actual)
July 7, 2016
Study Registration Dates
First Submitted
January 3, 2020
First Submitted That Met QC Criteria
January 15, 2020
First Posted (Actual)
January 18, 2020
Study Record Updates
Last Update Posted (Actual)
January 18, 2020
Last Update Submitted That Met QC Criteria
January 15, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCH-13-067b
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteogenesis Imperfecta
-
Ultragenyx Pharmaceutical IncMereo BioPharmaCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta, Type IUnited States, Canada, Denmark, France, United Kingdom
-
Nationwide Children's HospitalCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IIUnited States
-
Emory UniversityNot yet recruitingOsteogenesis Imperfecta | Osteogenesis Imperfecta Type III
-
Angitia Biopharmaceuticals Guangzhou LimitedNot yet recruitingA Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR) (EIR)Osteogenesis Imperfecta (OI)China
-
Istituto Ortopedico RizzoliRecruitingOsteogenesis Imperfecta | Osteogenesis Imperfecta (OI)Italy
-
University Hospital, GhentUniversity Ghent; Brittle Bone Society; Osteogenesis Imperfecta FederationRecruiting
-
AmgenTerminatedOsteogenesis Imperfecta (OI)Canada, Czechia, Spain, United Kingdom, United States, Italy, Hungary, Australia, Belgium, France, Germany, Poland
-
Novartis PharmaceuticalsCompletedOsteogenesis ImperfectaUnited States
-
Shriners Hospitals for ChildrenNovartisCompleted
-
Angitia Incorporated LimitedRecruitingOsteogenesis Imperfecta (OI)United States, France, Netherlands, Australia, Denmark, United Kingdom, Canada, Argentina
Clinical Trials on Thermal imaging device
-
North Florida Foundation for Research and EducationInfrared Cameras Incorporate; VivadoxNo longer available
-
Sheffield Children's NHS Foundation TrustCompleted
-
University of ArkansasWithdrawnPressure Ulcer | Decubitus UlcerUnited States
-
Massachusetts General HospitalCompletedThermal Imaging, Neonatal Pneumonia, TachypneaUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
University Hospitals, LeicesterAssociation of Anaesthetists of Great Britain and IrelandCompleted
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnStage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | Invasive Ductal Breast CarcinomaUnited States
-
Zhou XingchenCompleted
-
Sheffield Children's NHS Foundation TrustCompletedFracture | Abuse PhysicalUnited Kingdom